President Donald Trump, under fire over his handling of the coronavirus epidemic, announced that the federal government would ship 150 million rapid tests to U.S. states and warned an increase in positive cases is likely in the days ahead.
If you are not happy with the results below please do another search
50 search results for:
The number of new Covid-19 cases in the United States rose two weeks in a row in 27 out of 50 states, with North Carolina and New Mexico both reporting increases above 50% last week, according to a Reuters analysis.
Fingerpaint named industry veteran Tony Jerig as head of information technology and also appointed him to the full-service health and wellness marketing agency’s operating board.
Days after Johnson & Johnson moved JNJ-78436735 into Phase III development, the company posted an interim analysis of a Phase I/IIa trial that showed a single dose of the novel coronavirus vaccine candidate induced a strong neutralizing antibody response in nearly all participants and was well-tolerated.
The U.S. Food and Drug Administration is wrapping up the month of September with a few PDUFA dates, including an approval review of Aquestive’s Libervant for the management of seizure clusters in epilepsy.
Shares of Inovio Pharmaceuticals plunged in trading after the company reported the U.S. Food and Drug Administration placed a partial clinical hold on the planned Phase II/III study of the Covid-19 vaccine candidate INO-4800.
The U.S. Food and Drug Administration approved a supplemental New Drug Application for Shionogi & Co. Ltd.’s Fetroja (cefiderocol) for the treatment of patients 18 years of age or older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP).
Swiss drugmaker Roche said 59% of infants with the severest form of spinal muscular atrophy could sit for at least five seconds after getting the company’s medicine Evrysdi for two years, according to trial data, up from 33% after a year of treatment.
Ena Respiratory said a nasal spray that the Australian biotech company is developing to improve the human immune system to fight common cold and flu significantly reduced the growth of the coronavirus in a recent study on animals.
The number of tests coming back positive for Covid-19 is topping 25% in several states in the U.S. Midwest as cases and hospitalizations also surge in the region, according to a Reuters analysis.